✦ LIBER ✦

Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy

✍ Scribed by Patricia E. Penovich; L. James Willmore

Book ID: 109111373
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Tongue: English
Weight: 74 KB
Volume: 50
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1167.2009.02234.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acetazolamide for Prevention of Contrast

Acetazolamide for Prevention of Contrast-Induced Nephropathy: A New Use for an Old Drug

✍ Farahnak Assadi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 89 KB

Effects of early long-term treatment wit

Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model

✍ Emilio Russo; Rita Citraro; Francesca Scicchitano; Salvatore De Fazio; Ida Perro 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 267 KB

The effect of MK-801 on kindled seizures

The effect of MK-801 on kindled seizures: Implications for use and limitations as an antiepileptic drug

✍ John M. Williamson; Dr Eric W. Lothman 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Safe reduction of the cough reflex with

Safe reduction of the cough reflex with noscapine : A preliminary communication on a new use for an old drug

✍ R. E. Loder 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

New methods of preclinical testing of ti

New methods of preclinical testing of tiludronate, a drug for use in the prevention or treatment of postmenopausal osteoporosis and paget’s disease of bone

✍ A. Barbier; C. Martel; F. Lacheretz; Sanofi Recherche 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Adacolumn for selective leukocytapheresi

Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy?

✍ Abbi R. Saniabadi; Hiroyuki Hanai; Yasuo Suzuki; Toshihide Ohmori; Koji Sawada; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

Inflammatory and/or autoimmune diseases like ulcerative colitis (UC) or Crohn's disease (CD) are debilitating chronic disorders that poorly respond to pharmacological interventions. Further, drug therapy has adverse effects that add to disease complications. The current thinking is that disorders li